not tagged
bms
['sclc', 'lcsm,(-blcsm)', 'nsclc', 'bms', 'scienceatbms']
we are excited to be part of #asco22! join us in poster hall a or virtually to hear new 3-year and 5-year survival data with first-line dual #immunotherapy-based treatment with or without chemotherapy, in patients with metastatic. #nsclc #lcsm
Official Bristol Myers Squibb Twitter handle for science. Connecting researchers, scientists and healthcare professionals through science; guidelines below: